Dopamine, serotonin and tachykinin in self-injurious behavior

Life Sciences

Volumn 58, Issue 26, 1996, Pages 2367-2375

  Sivam, S P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

Author keywords

6 hydroxydopamine; D1 receptor; D2 receptor; dopamine; GBR 12909; Lesch Nyhan syndrome; neurokinin A; self injurious behavior; sensitization; serotonin; striatum; substance P; substantia nigra; tachykinin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; LEVODOPA; MESSENGER RNA; NEUROKININ A; OXIDOPAMINE; PREPROTACHYKININ; SEROTONIN; SUBSTANCE P; TACHYKININ; VANOXERINE; ZIMELDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOMUTILATION; BRAIN INJURY; DOPAMINE UPTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; LESCH NYHAN SYNDROME; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; RAT; SEROTONINERGIC SYSTEM; SHORT SURVEY;

ANIMALIA;

EID: 0029992395     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00121-X     Document Type: Short Survey

References (66)

1. P.H. ANDERSEN, Eur. J. Pharmacol. 166 493-504 (1989).
2. B.A. BALDO and A.E. KELLEY, Brain Res. Bull. 27 105-108 (1991).
3. M.J. BANNON, P.J. ELLIOTT and E.B. BUNNEY, Mol. Brain Res. 3 31-37 (1987).
4. A.A. BAUMEISTER and G. FRYE, Neurosci. Biobehav. Rev. 9 169-178 (1985).
5. G.R. BREESE, A.A. BAUMEISTER, T.J. MCCOWN, S.G. EMERICK, G.D. FRYE, K. CROTTY and R.A. MUELLER, J. Pharmacol. Exp. Ther. 231 343-354 (1984).
6. G.R. BREESE, A.A. BAUMEISTER, T.J. MCCOWN, S.G. EMERICK, G.D. FRYE and R.A. MUELLER, Pharmacol. Biochem. Behav. 21 459-461 (1984).
7. G.R. BREESE, H.E. CRISWELL, G.E. DUNCAN and R.A. MUELLER, Psychopharmacol. Bull. 25 353-357 (1989).
8. G.R. BREESE, H.E. CRISWELL, G.E. DUNCAN and R.A. MUELLER, Brain Res. Bull. 25 477-484 (1990).
9. G.R. BREESE, H.E. CRISWELL, K.B. JOHNSON, J.P. O'CALLAGHAN, G.E. DUNCAN, K.F. JENSEN, P.E. SIMSON and R.A. MUELLER, Neurotoxicology 15 149-160 (1994).
10. G.R. BREESE, R.A. MUELLER, C.T. NAPIER and E. DUNCAN, Adv. Exp. Med. Biol. 204 197-215 (1988).
11. N.S. BRYSON, N. SAKATI, W.L. NYHAN and C.H. FISH. J. Mental Deficiency Res. 76 319-324 (1971).
12. J.K. BUITELAAR, Acta Paedopsychiatrica 56 105-111 (1993).
13. M.F. CATALDO and J. HARRIS, Analysis Intervention Dev. Disabilities 2 21-39 (1982).
14. H.T. CHANG, Brain Res. 448 391-396 (1988).
15. S. FERRE, R. CORTES and F. ARTIGAS, J. Neurosci. 14 4839-4846 (1994).
16. M. GOLDSTEIN, Psychopharmacol. Bull. 25 349-352 (1989).
17. M. GOLDSTEIN, S. KUGA, N. KUSANO, E. MELLER, J. DANCIS and R. SCHWARCZ, Brain Res. 367 114-120 (1986).
18. A.H. GREEN, Arch. Gen. Psychiat. 17 234-244 (1967).
19. G.R. HANSON, N. SINGH, K. MERCHANT, M. JOHNSON and J.W. GIBB. Drug Alcohol Depend. 37 107-110 (1995).
20. R.E. HEIKKILA and L. MANZINO, Eur. J. Pharmacol. 103 241-248 (1984).
21. O. HORNYKIEWICZ and S.J. KISH, Advances in Neurology, M.D. Yahr and K.J. Bergmann (eds), 19-33, Raven Press, New York (1986).
22. H.A. JINNAH, F.H. GAGE and T. FRIEDMANN, Brain Res. Bull. 25 467-475 (1990).
23. P.J. KARSTAEDT, H. KERASIDIS, J. PINCUS, R. MELONI, J. GRAHAM and K. GALE, Exp. Neurol. 126 25-30 (1994).
24. Y. KAWAI, H. TAKAGI, Y. KUMOI, S. SHIOSAKA and M. TOHYAMA, Brain Res. 401 371-376 (1987).
25. B.H. KING, Am. J. Mental Retard. 98 93-112 (1993).
26. M.S. KLEVEN, W.L. WOOLVERTON and L.S. SEIDEN, Brain Res. Bull. 21 233-237 (1988).
27. Y. KUBOTA, S. INAGAKI and S. KITO, Brain Res. 375 163-167 (1986).
28. Y. KUBOTA, S. INAGAKI, S. KITO and A.D. SMITH, Brain Res. 367 374-378 (1986).
29. Y. KUBOTA, S. INAGAKI, S. KITO and J. WU, Brain Res. 406 147-156 (1987)
30. M. LESCH and W.L. NYHAN, Am. J. Med. 36 561-570 (1964).
31. S. LI, S.P. SIVAM and J.S. HONG, Brain Res. 1-4 (1986).
32. S.J. LI, H.K. JIANG, M.S. STACHOWIAK, P.M. HUDSON, V. OWYANG, K. NANRY, H.A. TILSON and J.S. HONG, Mol. Brain Res. 8 219-225 (1990).
33. S.J. LI, S.P. SIVAM, J.F. MCGINTY, H.K. JIANG, J. DOUGLASS, L. CALAVETTA and J.S. HONG, J. Pharmacol. Exp. Ther. 246 403-408 (1988).
34. K.G. LLOYD, O. HORNYKIEWICZ, L. DAVIDSON, K. SHANNAK, I. FARLEY, M. GOLDSTEIN, M. SHIBUYA, W.N. KELLEY and I.H. FOX, N. Engl. J. Med. 305 1106-1111 (1981).
35. C.R. MAISTO, A.A. BAUMEISTER and A.A. MAISTO, J. Mental Deficiency Res. 22 27-36 (1978).
36. G.J. MAREK, G. VOSMER and L.S. SEIDEN. Brain Res. 516 1-7 (1990).
37. M.E. REITH, L.L. COFFEY, C. XU and N.H. CHEN. Eur. J. Pharmacol. 253 175-178 (1994).
38. R.B. ROTHMAN, N. GRIEG, A. KIM, B.R. DECOSTA, K.C. RICE, F.I. CARROLL and A. PERT, Pharmacol. Biochem. Behav. 43, 1135-1142 (1992).
39. P. SEEMAN and H.H.M. VAN TOL, TIPS 15 264-270 (1994).
40. S.P. SIVAM, Brain Res. 500 119-130 (1989).
41. S.P. SIVAM, J. Pharmacol. Exp. Ther. 250 818-824 (1989).
42. S.P. SIVAM, Neuropeptides 18 201-207 (1991).
43. S.P. SIVAM, Soc. Neurosci. Abst. 20 228 (1994).
44. S.P. SIVAM, Life Sci. 56 PL467-472 (1995).
45. S.P. SIVAM, Neurosci. Res. Comm. 17 209-215 (1995).
46. S.P. SIVAM, Mol. Brain Res. (1995) In Press.
47. S.P. SIVAM, Brain Res. 690 259-263 (1995).
48. S.P. SIVAM, G.R. BREESE, J.E. KRAUSE, T.C. NAPIER, R.A. MUELLER and J.-S. HONG, J. Neurochem. 49 1623-1633 (1987).
49. S.P. SIVAM and J.E. KRAUSE, J. Pharmacol. Exp. Ther. 254 433-439 (1990).
50. S.P. SIVAM and J.E. KRAUSE, Brain Res. 536 169-175 (1990).
51. S.P. SIVAM, J.E. KRAUSE, G.R. BREESE and J.-S. HONG, J. Neurochem. 56 1499-1508 (1991).
52. M.K. STACHOWIAK, J.P. BRUNO, A.M. SNYDER, E.M. STRICKER and M.J. ZIGMOND, Brain Res. 291 164-167 (1984).
53. A.C. TOWLE, H.E. CRISWELL, E.H. MAYNARD, J.M. LAUDER, T.H. JOH, R.A. MUELLER and G.R. BREESE, Pharmacol. Biochem. Behav. 34 367-374 (1989).
54. J.M. TRUGMAN and G.F. WOOTEN, J. Neurosci. 7 2927-2935 (1987).
55. J.M. TRUGMAN and G.F. WOOTEN, Brain Res. 379 264-274 (1988).
56. G.R. UHL, TINS 15 265-268 (1992).
57. P. VAN DER ZEE, H.S. KOGER, J. GOOTJES and W. HESPE, Eur. J. Med. Chem. 15 363-370 (1980).
58. M.H. VAN WOERT, R. JUTKOWITZ, D. ROSENBAUM and M.B. BOWERS, The Basal Ganglia, M.D. Yahr (ed), 459-465, Raven Press, New York (1976).
59. S. VINCENT, T. HOKFELT, I. CHRISTENSSON and L. TERENIUS, Eur. J. Pharmacol. 85 251-252 (1985).
60. P.D. WALKER, L.A. RILEY, R.P. HART and G.M. JONAKAIT, Brain Res. 546 33-39 (1991).
61. P.D. WALKER, L.A. RILEY, R.P. HART and G.M. JONAKAIT, Brain Res. 557 31-36 (1991).
62. J.M. WILSON, A.B. YOUNG and W.N. KELLERY, N. Engl. J. Med. 309 100-110 (1983).
63. R.M. WINCHEL and M. STANLEY, Am. J. Psychiatry 148 306-317 (1991).
64. K. WU and I.B. BLACK, Proc. Natl. Acad. Sci. USA 84 8687-8691 (1987).
65. H.-Y. YANG, J.S. HONG and E. COSTA, Neuropharmacology 16 303-307 (1977).
66. N. ZAMIR, M. PALKOVITS, E. WEBER, E. MEZEY and M.J. BROWNSTEIN, Nature 307 (1984).